Definium Therapeutics, Inc. Common Shares (DFTX) is a publicly traded the market company. As of July 14, 2026, DFTX trades at $44.19 with a market cap of $6.25B and a P/E ratio of 0.00. DFTX moved +1.65% today. Year to date, DFTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.62 to $49.20. Analyst consensus is strong buy with an average price target of $56.83. Rallies surfaces DFTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
12 analysts cover DFTX: 0 strong buy, 12 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $56.83.
| Metric | Value |
|---|---|
| Price | $44.19 |
| Market Cap | $6.25B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.20 |
| 52-Week Low | $14.62 |
| Volume | 160.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
12 analysts cover DFTX: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.83.